Relmada Therapeutics, Inc.

UBS Group AG RLMD

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

41,468

Value ($000)

200

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	200	0.0%	41,468	12/31/2025
2025 Q3	11/13/2025	120	0.0%	59,785	9/30/2025
2025 Q2	8/14/2025	108	0.0%	180,471	6/30/2025
2025 Q1	5/13/2025	39	0.0%	144,789	3/31/2025
2024 Q4	2/14/2025	112	0.0%	215,140	12/31/2024
2024 Q3	11/14/2024	409	0.0%	126,385	9/30/2024
2024 Q2	8/14/2024	386	0.0%	128,800	6/30/2024
2024 Q1	5/13/2024	601	0.0%	129,285	3/31/2024
2023 Q4	2/9/2024	521	0.0%	125,730	12/31/2023
2023 Q3	11/9/2023	377	0.0%	125,688	9/30/2023
2023 Q2	8/11/2023	244	0.0%	98,988	6/30/2023
2023 Q1	5/12/2023	4	0.0%	1,578	3/31/2023
2022 Q4	2/8/2023	21	0.0%	5,913	12/31/2022
2022 Q3	11/10/2022	225	0.0%	6,084	9/30/2022
2022 Q2	8/10/2022	25	0.0%	1,328	6/30/2022
2022 Q1	5/16/2022	36	0.0%	1,328	3/31/2022
2021 Q4	2/14/2022	72	0.0%	3,197	12/31/2021
2021 Q3	11/15/2021	124	0.0%	4,719	9/30/2021
2021 Q2	8/13/2021	148	0.0%	4,621	6/30/2021
2021 Q1	5/12/2021	230	0.0%	6,546	3/31/2021
2020 Q4	2/11/2021	238	0.0%	7,419	12/31/2020
2020 Q3	11/12/2020	211	0.0%	5,614	9/30/2020
2020 Q2	7/31/2020	374	0.0%	8,361	6/30/2020
2020 Q1	5/1/2020	104	0.0%	3,043	3/31/2020
2019 Q4	2/14/2020	166	0.0%	4,257	12/31/2019